Why AdaptHealth (AHCO) Stock Is Trading Lower Today
AdaptHealth Corp. (AHCO) shares fell about 39.5% after its Q2 results missed expectations and it cut full-year guidance. The company reported a GAAP loss of $0.99 per share versus a $0.15 gain estimate, and revenue of $740.3 million versus $847.2 million expected. It lowered 2026 revenue guidance midpoint to $2.87B from $3.49B and adjusted EBITDA to $490M-$520M, citing West Coast partnership issues and a manufacturer price increase.
How this was made
The 30-second read
Why it matters
The key tradable change is the quantified guidance reduction for 2026 revenue and adjusted EBITDA, attributed to West Coast partnership challenges and an unexpected manufacturer price increase.
Market read
This is a direct earnings and guidance shock with hard numbers, making it a high-signal catalyst for traders managing exposure to AHCO and the broader home medical equipment group.
What to watch
Investors may be underweighting the gap between revenue and profitability drivers, and the potential for margin recovery if manufacturer pricing normalizes and the West Coast partnership issues resolve.
Background
AdaptHealth is a home medical equipment provider, and the article frames today’s move as a reaction to a Q2 earnings miss plus a large full-year guidance reset.
Ticker impact
AdaptHealth shares fell 39.5% after Q2 results missed expectations and the company cut 2026 revenue guidance to a $2.87B midpoint.
Bearish near-term bias, with volatility likely to remain elevated as the market reprices 2026 growth and EBITDA margins.
The article cites a large same-day drop tied directly to a quantified earnings miss and a substantial full-year guidance reduction, plus stated drivers (West Coast partnership challenges, unexpected manufacturer price increase).
Market effects
Signals heightened execution and pricing risk in home medical equipment services, potentially pressuring sentiment across similar providers.
West Coast partnership issues are company-specific but may raise regional execution concerns for operators with similar footprint.
Limited direct global spillover; impact is primarily within US healthcare services and equipment supply chains.
Counterpoint
The magnitude of the selloff could be overdone if the guidance cut is driven by temporary partnership and pricing disruptions rather than structural demand weakness.
Key entities
- companyAdaptHealth Corp.
Home medical equipment provider whose Q2 results and 2026 guidance were cut, triggering a sharp selloff.
- business factorWest Coast partnership
Stated driver of the lowered outlook, implying execution risk in a key regional relationship.
- business factorManufacturer price increase
Stated driver of margin pressure and reduced adjusted EBITDA outlook.
